Mandatory information

mandatory information Bromelain-POS®

500 FIP units, gastro-resistant tablets.
 Active ingredient: bromelain.
 Therapeutic indications: supportive treatment of post-operative and post-traumatic swelling, particularly that of the nose and sinuses. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. November 2020
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.

View all madatory information